Astera Labs shares gain around 4.5% after strong institutional positioning ahead of earnings release

Traders Union
All News
Stocks
Astera Labs rises 4.45% today

Highlights

Astera Labs expects fiscal third quarter 2026 earnings per share of $1.16 to $1.21 on revenue of $540 million to $560 million.
The Scorpio X-Series has become the company’s largest product family ahead of schedule, with accelerated customer adoption in AI infrastructure connectivity.
Astera Labs stock faces broad downward pressure, with technicals projecting a $202.66 to $277.13 trading range and a high probability of further downside.

Earnings optimism and Scorpio X momentum spur institutional flows

Astera Labs is scheduled to report its fiscal third quarter 2026 earnings after the U.S. market closes on November 3, 2026, with prior guidance targeting earnings per share between $1.16 and $1.21 and revenue between $540 million and $560 million. The company's Scorpio X-Series product line has become its largest family ahead of plan, reflecting stronger-than-expected customer adoption in AI infrastructure connectivity. Institutional investors, including Sumitomo Mitsui Trust Group, have increased their holdings in the third quarter, fueling investor interest ahead of the earnings event.

Anton Kharitonov, expert at Traders Union, believes Astera Labs’ short-term rally is unlikely to be sustainable. He notes that the stock’s technical profile stays bearish, with prices held below key moving averages and weak momentum. Kharitonov highlights that, despite positive headlines about institutional buying and product adoption, the inability to break resistance signals limited upside. He points to persistent seller control and sees downside risk if support at $235.33 fails. “Market optimism seems overextended — I expect sellers to remain dominant barring a clear technical reversal.”

Viktoras Karapetjanc, expert at Traders Union, sees opportunity emerging as institutional investors increase their exposures ahead of earnings. He views robust customer adoption of the Scorpio X-Series and strong fiscal outlook as key positives. Karapetjanc believes the news flow and forward guidance set the stage for an eventual recovery, even while volatility persists. “Momentum is likely to build as fundamentals improve, so further growth should not be ruled out in upcoming sessions.”

Jainam Mehta, market strategist, observes Astera Labs trading in a compressed band between $202.66 and $277.13 as volatility remains high. Mehta notes that oversold technical signals could create contrarian entry points if institutional sentiment turns positive post-earnings. He suggests tactical upside exists only on a sustained move above $249.5. “Traders should watch for a potential breakout or sharp reversal as sentiment and positioning realign.”

Persistent bearish momentum as volatility tests oversold technicals

Astera Labs trades below its 20-day, 50-day, and 200-day moving averages at $299.8, $307, and $255.51, pointing to persistent downward pressure. Immediate technical levels are defined by the support at $235.33 and resistance at $249.5, with higher resistance ranges confirming a bearish bias. Momentum remains weak, as signaled by the MACD and ADX, while the Relative Strength Index (RSI) is neutral. Both the Stochastic RSI and Commodity Channel Index (CCI) indicate oversold conditions, suggesting seller exhaustion risk but with no clear rebound signal. Bull/Bear Power highlights seller control, and the Awesome Oscillator does not establish a strong trend direction. The stock has displayed significant intraday volatility, with early gains giving way to renewed selling pressure.

Earlier, analysts noted that Astera Labs faced persistent selling pressure and maintained a broadly bearish technical setup despite robust fundamental growth. The current advance highlights short-term buying interest but does not alter the prevailing downside risk, with traders advised to closely monitor the $235.33 support level as a potential trigger for renewed volatility.

Source of Data: ALAB Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.